Tenapanor Scores FDA Advisory Committee Endorsement
An FDA advisory committee said the benefits of tenapanor for treating hyperphosphatemia in patients on dialysis outweighed its risks as both mono- and combo-therapy.
Stay updated with breaking news from Response Letter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An FDA advisory committee said the benefits of tenapanor for treating hyperphosphatemia in patients on dialysis outweighed its risks as both mono- and combo-therapy.
WASHINGTON (dpa-AFX) - Shares of BioMarin Pharmaceutical Inc. (BMRN) gained nearly 5% in extended trading session Wednesday after the company announced that the U.S. Food and Drug Administration
Closing Bell: Meek Monday belies terrifying Tuesday RBA meet and awful OPEC idea; DNK up 30% on potash sale
Appoints Timothy E. Morris, a veteran biotech executive with over 35 years of experience in executive and financial leadership, to Board of DirectorsNames...
The United States Department of Agriculture (USDA) issued a document entitled Thrifty Food Plan, 2021 (2021 TFP). The 2021 TFP updates the market...